These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 9080995

  • 1. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study.
    Gall MA, Hougaard P, Borch-Johnsen K, Parving HH.
    BMJ; 1997 Mar 15; 314(7083):783-8. PubMed ID: 9080995
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.
    Rossing P, Hougaard P, Borch-Johnsen K, Parving HH.
    BMJ; 1996 Sep 28; 313(7060):779-84. PubMed ID: 8842069
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study.
    Rossing P, Hougaard P, Parving HH.
    Diabetes Care; 2002 May 28; 25(5):859-64. PubMed ID: 11978681
    [Abstract] [Full Text] [Related]

  • 5. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients.
    Wirta OR, Pasternack AI, Mustonen JT, Koivula TA, Harmoinen A.
    Nephrol Dial Transplant; 1996 Mar 28; 11(3):449-56. PubMed ID: 8671814
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.
    Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R.
    Arch Intern Med; 1998 May 11; 158(9):998-1004. PubMed ID: 9588433
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.
    Mathiesen ER, Hommel E, Giese J, Parving HH.
    BMJ; 1991 Jul 13; 303(6794):81-7. PubMed ID: 1860008
    [Abstract] [Full Text] [Related]

  • 9. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes.
    Powrie JK, Watts GF, Ingham JN, Taub NA, Talmud PJ, Shaw KM.
    BMJ; 1994 Dec 17; 309(6969):1608-12. PubMed ID: 7819935
    [Abstract] [Full Text] [Related]

  • 10. Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens.
    Nelson RG, Knowler WC, Pettitt DJ, Saad MF, Charles MA, Bennett PH.
    Arch Intern Med; 1991 Sep 17; 151(9):1761-5. PubMed ID: 1888242
    [Abstract] [Full Text] [Related]

  • 11. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study.
    Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, Binder C, Parving HH.
    BMJ; 2004 May 08; 328(7448):1105. PubMed ID: 15096438
    [Abstract] [Full Text] [Related]

  • 12. Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria.
    Chiarelli F, Catino M, Tumini S, de Martino M, Mezzetti A, Verrotti A, Vanelli M.
    Diabetes Care; 1999 Jul 08; 22(7):1158-64. PubMed ID: 10388982
    [Abstract] [Full Text] [Related]

  • 13. The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study.
    Mathiesen ER, Rønn B, Storm B, Foght H, Deckert T.
    Diabet Med; 1995 Jun 08; 12(6):482-7. PubMed ID: 7648820
    [Abstract] [Full Text] [Related]

  • 14. Incipient and overt diabetic nephropathy in African Americans with NIDDM.
    Dasmahapatra A, Bale A, Raghuwanshi MP, Reddi A, Byrne W, Suarez S, Nash F, Varagiannis E, Skurnick JH.
    Diabetes Care; 1994 Apr 08; 17(4):297-304. PubMed ID: 8026285
    [Abstract] [Full Text] [Related]

  • 15. Urinary albumin excretion is correlated to fibrinogen levels and protein S activity in patients with type 1 diabetes mellitus without overt diabetic nephropathy.
    Lengyel Z, Vörös P, Tóth LK, Németh C, Kammerer L, Mihály M, Tornóci L, Rosivall L.
    Wien Klin Wochenschr; 2004 Apr 30; 116(7-8):240-5. PubMed ID: 15143863
    [Abstract] [Full Text] [Related]

  • 16. Increased glomerular filtration rate as a predictor of diabetic nephropathy--an 8-year prospective study.
    Rudberg S, Persson B, Dahlquist G.
    Kidney Int; 1992 Apr 30; 41(4):822-8. PubMed ID: 1513104
    [Abstract] [Full Text] [Related]

  • 17. Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study.
    Lindhardt M, Persson F, Zürbig P, Stalmach A, Mischak H, de Zeeuw D, Lambers Heerspink H, Klein R, Orchard T, Porta M, Fuller J, Bilous R, Chaturvedi N, Parving HH, Rossing P.
    Nephrol Dial Transplant; 2017 Nov 01; 32(11):1866-1873. PubMed ID: 27507891
    [Abstract] [Full Text] [Related]

  • 18. Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai Urban Rural Epidemiology Study (CURES 45).
    Unnikrishnan RI, Rema M, Pradeepa R, Deepa M, Shanthirani CS, Deepa R, Mohan V.
    Diabetes Care; 2007 Aug 01; 30(8):2019-24. PubMed ID: 17488949
    [Abstract] [Full Text] [Related]

  • 19. [Risk factors for mortality in patients with insulin-dependent diabetes].
    Rossing P, Hougaard P, Borch-Johnsen K, Parving HH.
    Ugeskr Laeger; 1998 Feb 23; 160(9):1315-9. PubMed ID: 9495080
    [Abstract] [Full Text] [Related]

  • 20. [Factors influencing incipient diabetic nephropathy: ESODIAH study].
    Biarnés J, Masana L, Morales C, Pintó X, Ricart W, Grupo del estudio ESODIAH.
    Med Clin (Barc); 2005 Oct 01; 125(11):401-4. PubMed ID: 16216183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.